Food and Drug Administration grant notices posted in 2021, now closed
60 Food and Drug Administration grant notices posted on Grants.gov in 2021 that have closed, with their numbers and dates.
- RFA-FD-22-006: Conformance with the Egg Regulatory Program Standards (U2F) [Clinical Trial Not Allowed]
- RFA-FD-22-004: Renewal - Cooperative Agreement to Support the Joint Institute for Food Safety and Applied Nutrition, JIFSAN (U01) Clinical Trial Not Allowed
- RFA-FD-22-003: Innovation Award: COVID-19 and Health Equity (U01) Clinical Trials Optional
- FOR-FD-20-002: FDA's National Curriculum Standard Development and Training Delivery and Development (ORA/OTED) (U18) Clinical Trial Not Allowed
- FOR-FD-20-003: Integrated Pathogen Reduction Technologies for whole blood and blood components for transfusion (R01) Clinical Trial Not Allowed
- FOR-FD-20-005: Development and Maintenance of the Animal Feed Regulatory Program Standards with Optional Coordinated Preventive Control Regulatory Activities and Capacity Building (U18) Clinical Trial Not Allowed
- FOR-FD-20-001: An evidence-based clinical practice guideline for dental pain (surgical and non-surgical)
- FOR-FD-20-004: Retail Food Safety Association Collaboration (U18) Clinical Trial Not Allowed
- FOR-FD-20-006: NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens (U01) Clinical Trials Not Allowed
- FOR-FD-20-007: Exploring the use of Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making (U01) Clinical Trials Optional
- FOR-FD-20-008: Incorporating cost effectiveness & societal outcomes into FDA opioids model (U01)
- FOR-FD-20-009: Smoking Machine Adaptor Design Project for ENDS, Cigars, and Heated Tobacco Products
- FOR-FD-20-010: Drug Development Science Support (U01)
- FOR-FD-20-011: CBER FY20 FOA for AAV vector manufacturing for diseases affecting very small populations (R01) Clinical Trial Not Allowed
- FOR-FD-20-013: Development of methods for evaluating the impact of small design differences in the user interface of drug-device combination products on generic substitutability
- FOR-FD-20-014: PBPK Models to Aid the Development of Generic Dermatological Products
- FOR-FD-20-015: PBPK Models of Oral Absorption to Simulate the Results of Bioequivalence Studies
- FOR-FD-20-018: Implementation of the National Evaluation System for Health Technology (NEST) Coordinating Center (CC)
- FOR-FD-20-023: CFD Models to aid the development of generic inhalation products
- FOR-FD-20-020: Manufactured Food Regulatory Program Alliance
- FOR-FD-20-021: Advance conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS)
- FOR-FD-20-024: Analgesic, Anesthetic and Addiction Clinical Trials Innovations, Opportunities, and Networks (ACTTION)
- FOR-FD-20-25: SmartTots (Strategies for Mitigating Anesthesia-Related neuroToxicity in Tots) Public-Private Partnership
- FOR-FD-20-025: Quantify the expression of metabolizing enzymes and transporter proteins in lung, eye and skin tissue in relevant animal models and humans
- FOR-FD-20-028: Impulse Oscillometry Endpoint Sensitivity to Regional Lung Function Changes using Computational Fluid Dynamics (CFD)
- FOR-FD-20-027: Dermal Physiologically-Based Pharmacokinetic (PBPK) Models Accounting for the Absorption and Evaporation of Vehicle/Co-Solvent Following the Application of Generic Dermatological Products
- FOR-FD-20-029: Expanding the Opioids System Model to more comprehensively incorporate fentanyl, stimulants use, polysubstance use and associated outcomes.
- FOR-FD-20-030: Development of a model selection method for population pharmacokinetics analysis by deep-learning based reinforcement learning
- FOR-FD-20-031: Drug Development Tools Research Grants (U01 Clinical Trial Optional)
- FOR-FD-21-004: Minor Use Minor Species Development of Drugs (R01) Clinical Trials Not Allowed
- FOR-FD-21-006: Enhancing Innovations in Advanced Manufacturing Technologies for Vaccines against Influenza and Emerging Infectious Diseases
- FOR-FD-21-007: AAV Vector manufacturing for diseases affecting very small populations
- RFA-FD-21-032: Integrated Pathogen Reduction Technologies for whole blood and blood components for transfusion (R01) Clinical Trials Not Allowed
- RFA-FD-21-035: Pediatric and Perinatal COVID-19 Registry (U18) Clinical Trials Optional
- RFA-FD-21-025: SmartTots (Strategies for Mitigating Anesthesia-Related neuroToxicity in Tots) Public-Private Partnership (PPP) under PASI (Pediatric Anesthesia Safety Initiative) (U01) Clinical Trials Not Allowed
- RFA-FD-21-031: Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products (U01) Clinical Trials Not Allowed
- RFA-FD-21-034: AAV Vector manufacturing for diseases affecting very small populations (R01) Clinical Trials Not Allowed
- RFA-FD-21-030: Strategies that Support Global Food Safety (U01) Clinical Trial Not Allowed
- RFA-FD-21-25: SmartTots (Strategies for Mitigating Anesthesia-Related neuroToxicity in Tots) Public-Private Partnership (PPP) under PASI (Pediatric Anesthesia Safety Initiative) (U01) Clinical Trials Not Allowed
- RFA-FD-21-026: Analgesic, Anesthetic and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) (U01) Clinical Trials Not Allowed
- RFA-FD-21-033: Enhancing Innovations in Advanced Manufacturing Technologies for Vaccines against Influenza and Emerging Infectious Diseases (R01) Clinical Trials Not Allowed
- RFA-FD-21-022: Expanding the opioids system modeling efforts to more comprehensively address fentanyl, stimulants use, polysubstance use and associated outcomes.(U01) Clinical Trials Not Allowed
- RFA-FD-22-002: Data Standards for Tobacco Research and Scientific Review Program (U24) Clinical Trial Not Allowed
- RFA-FD-21-020: Impulse Oscillometry Endpoint Sensitivity to Regional Lung Function Changes using Computational Fluid Dynamics (CFD) (U01) Clinical Trial Required
- RFA-FD-21-017: Renewal : UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (U01) Clinical Trials Optional
- RFA-FD-21-029: Alliance to Support Integrated Food Safety System (IFSS) Activities (U2F) Clinical Trials Not Allowed
- PAR-21-178: Drug Development Tools Research Grants (U01) Clinical Trial Optional
- PAR-21-179: Minor Use Minor Species Development of Drugs (R01)
- PAR-21-174: The FDA's Cooperative Agreement Program for States and Territories to Implement a National Produce Safety Program (U2F) Clinical Trials Not Allowed
- RFA-FD-22-001: Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01) Clinical Trials Not Required
- RFA-FD-21-024: Training Alliance to Enhance Produce Safety and FDA Food Safety Modernization Act Compliance (U2F) Clinical Trial Not Allowed
- RFA-FD-21-019: Dermal Physiologically-based Pharmacokinetic (PBPK) Models Accounting for the Absorption and Evaporation of Vehicle/Co-solvent following the Application of Generic Dermatological Products (U01)
- RFA-FD-21-028: Advancing Conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS) by State, Local, Tribal, and Territorial (SLTT) Retail Food Regulatory Agencies (U2F) Clinical Trials Not Allowed
- RFA-FD-21-021: Renewal - Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations (U01) Clinical Trial Required
- RFA-FD-21-023: National Food and Nutrient Analysis Program (U01) Clinical Trial Not Applicable
- RFA-FD-21-012: Physiologically Based Pharmacokinetic (PBPK) Models of Oral Absorption to Simulate the Results of Bioequivalence Studies (U01) Clinical Trials Optional
- RFA-FD-21-015: Computational Fluid Dynamics (CFD) Models to Aid the Development of Generic Inhalation Products (U01) Clinical Trials Optional
- RFA-FD-21-018: Quantify the expression of metabolizing enzymes and transporter proteins in lung, eye and skin tissue in relevant animal models and humans (U01) Clinical Trial Not Allowed
- RFA-FD-21-027: Development of a model selection method for population pharmacokinetics analysis by deep-learning based reinforcement learning (U01) Clinical Trials Not Allowed
- RFA-FD-21-016: Development of Advanced Analytical Methods for the Characterization of Iron Carbohydrate Complex - Ferric Derisomaltose (U01) Clinical Trials Not Allowed